This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $4,214.88 Firm Fixed Price Delivery Order is for the supply of "MENQUADFI VIAL 0.5ML" medical products. The contract has an ultimate completion date of May 10, 2024. Amerisourcebergen holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, is a delivery order valued at $2,317.34 for the provision of MENQUADFI VIAL 0.5ML medical products. The award was made on May 15, 2024 by the Defense Logistics Agency (DLA), a defense agency, with a period of performance through May 16, 2024. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,794.69 firm fixed-price delivery order contract is for MENQUADFI VIAL 0.5ML medical supplies, with a performance period through January 22, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The U.S. government has awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a variety of pharmaceutical products and medical supplies. The contract, valued at $1,059.60, is a firm fixed-price delivery order contract that runs through July 2024. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that supports the healthcare needs of military personnel, veterans, and other federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $14,378.56, is a delivery order that will provide a variety of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,451.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of MENQUADFI VIAL 0.5ML medical products, with a period of performance through December 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $9,039.53, is for MENQUADFI VIAL 0.5ML medical supplies. The contract has a period of performance through January 9, 2025 and is a firm fixed-price delivery order. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award, valued at $156,868.14, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order that is Firm Fixed Price, with a performance period through December 22, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,115.52 firm fixed price delivery order is for the provision of MENQUADFI VIAL 0.5ML pharmaceutical products. The contract has an ultimate completion date of April 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This contract award, valued at $14,515.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...